- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Biogen Idec Inc+ Add to Watchlist
BIIB:US225.1800 USD 1.6700 0.74%
As of 17:20:00 ET on 05/20/2013.
Company Profile for Biogen Idec Inc (BIIB)
Biogen Idec Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company's products addresses diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, Crohn's disease, and psoriasis.
Biogen Idec Inc
Key Executives for Biogen Idec Inc (BIIB)
|William D Young "Bill"Chairman||George A ScangosChief Executive Officer|
|Susan H AlexanderExec VP/Chief Legal Ofcr/Secy||Paul J ClancyExec VP:Finance/CFO|
|Kenneth A DipietroExec VP:Human Resources||Stephen H Holtzman "Steve"Exec VP:Corp Development|
|Stuart A Kingsley "Tony"Exec VP:Global Commercial Ops||John G CoxExec VP:Pharmaceutical|
|Douglas Edward Williams "Doug"Exec VP:Research & Dev||Claudine ProwseVP:Investor Relations|